These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 658111)

  • 1. The pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. I. Lignocaine.
    Mihaly GW; Moore RG; Thomas J; Triggs EJ; Thomas D; Shanks CA
    Eur J Clin Pharmacol; 1978 May; 13(2):143-52. PubMed ID: 658111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration. Simultaneous investigation of absorption and disposition kinetics using stable isotopes.
    Burm AG; Vermeulen NP; van Kleef JW; de Boer AG; Spierdijk J; Breimer DD
    Clin Pharmacokinet; 1987 Sep; 13(3):191-203. PubMed ID: 3665324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. 11 Etidocaine.
    Morgan D; McQuillan D; Thomas J
    Eur J Clin Pharmacol; 1978 Jul; 13(5):365-71. PubMed ID: 668795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of lignocaine.
    Benowitz NL; Meister W
    Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of lignocaine in children following caudal anaesthesia.
    Ecoffey C; Desparmet J; Berdeaux A; Maury M; Giudicelli JF; Saint-Maurice C
    Br J Anaesth; 1984 Dec; 56(12):1399-402. PubMed ID: 6498050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.
    Orlando R; Piccoli P; De Martin S; Padrini R; Palatini P
    Br J Clin Pharmacol; 2003 Jan; 55(1):86-93. PubMed ID: 12534644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lignocaine kinetics in cardiac patients and aged subjects.
    Nation RL; Triggs EJ; Selig M
    Br J Clin Pharmacol; 1977 Aug; 4(4):439-48. PubMed ID: 901735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).
    Besunder JB; Reed MD; Blumer JL
    Clin Pharmacokinet; 1988 Apr; 14(4):189-216. PubMed ID: 3292100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.
    Barchowsky A; Shand DG; Stargel WW; Wagner GS; Routledge PA
    Br J Clin Pharmacol; 1982 Mar; 13(3):411-5. PubMed ID: 7059443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. III. Mepivacaine.
    Moore RG; Thomas J; Triggs EJ; Thomas DB; Burnard ED; Shanks CA
    Eur J Clin Pharmacol; 1978 Nov; 14(3):203-12. PubMed ID: 729615
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of ranitidine on the disposition of lignocaine.
    Robson RA; Wing LM; Miners JO; Lillywhite KJ; Birkett DJ
    Br J Clin Pharmacol; 1985 Aug; 20(2):170-3. PubMed ID: 4041336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.
    Perucca E; Hedges A; Makki KA; Richens A
    Br J Clin Pharmacol; 1980 Nov; 10(5):491-7. PubMed ID: 7437261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lignocaine kinetics in the rat.
    Supradist S; Notarianni LJ; Bennett PN
    J Pharm Pharmacol; 1984 Apr; 36(4):240-3. PubMed ID: 6144770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lignocaine gel used for lubrication of intranasal and endotracheal tubes in premature neonates.
    Bendixen D; Halvorsen AC; Hjelt K; Flachs H
    Acta Paediatr; 1994 May; 83(5):493-7. PubMed ID: 8086725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of lidocaine in fetal and neonatal lambs and adult sheep.
    Morishima HO; Finster M; Pedersen H; Fukunaga A; Ronfeld RA; Vassallo HG; Covino BG
    Anesthesiology; 1979 May; 50(5):431-6. PubMed ID: 453562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.
    Perucca E; Richens A
    Br J Clin Pharmacol; 1979 Jul; 8(1):21-31. PubMed ID: 552293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of local anaesthetics.
    Tucker GT; Mather LE
    Clin Pharmacokinet; 1979; 4(4):241-78. PubMed ID: 385208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of age on lignocaine pharmacokinetics in young puppies.
    Hastings CL; Brown TC; Eyres RL; Oppenheim RC
    Anaesth Intensive Care; 1986 May; 14(2):135-9. PubMed ID: 3740386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.